Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Yoshinori Ozono"'
Autor:
Yuri Komaki, Yoshinori Ozono, Kenichi Nakamura, Hisayoshi Iwakiri, Satoru Hasuike, Mitsue Sueta, Tadashi Miike, Shojiro Yamamoto, Hirofumi Uto, Kazunori Kusumoto, Toshimasa Ochiai, Junya Kato, Naoto Komada, Kazuo Kuroki, Toshiharu Eto, Masafumi Shigehira, Shuichi Hirono, Kenji Nagata, Hiroshi Kawakami
Publikováno v:
BMC Gastroenterology, Vol 22, Iss 1, Pp 1-9 (2022)
Abstract Background It is estimated that approximately 50% of patients with hepatitis C virus (HCV) infection in Japan are currently over 75 years old. However, patients aged ≥ 75 years are typically underrepresented in clinical trials of direct-ac
Externí odkaz:
https://doaj.org/article/7474353ef2834ff3a2f22d0d85ec24a5
Autor:
Satoru Hasuike, Yoshinori Ozono, Keisuke Uchida, Souichiro Ogawa, Hotaka Tamura, Naomi Uchiyama, Hiroshi Hatada, Yuri Komaki, Kenichi Nakamura, Hisayoshi Iwakiri, Mitsue Sueta, Kenji Nagata, Toyoki Nishimura, Misayo Matsuyama, Hirotake Sawada, Toshiyuki Oguri, Yuichiro Sato, Hiroshi Kawakami
Publikováno v:
Medicine; 5/31/2024, Vol. 103 Issue 22, p1-6, 6p
Autor:
Satoru Hasuike, Kenji Nagata, Haruka Sasaki, Tomoya Hirata, Sho Suzuki, Yuri Komaki, Yoshinori Ozono, Kenichi Nakamura, Tadashi Miike, Hisayoshi Iwakiri, Mitsue Sueta, Shojiro Yamamoto, Kazuya Maekawa, Hiroshi Kawakami
Publikováno v:
Internal Medicine; 2023, Vol. 62 Issue 21, p3143-3149, 7p
Autor:
Keisuke Uchida, Yoshinori Ozono, Naomi Uchiyama, Hiroshi Hatada, Kenichi Nakamura, Yuri Komaki, Hisayoshi Iwakiri, Satoru Hasuike, Kenji Nagata, Yuichiro Sato, Hiroshi Kawakami
Publikováno v:
Medicine. 101(35)
Hepatocellular carcinoma (HCC) is the sixth most common type of cancer globally. Since 2020, combination treatment with atezolizumab and bevacizumab were approved in patients with unresectable HCC in Japan, and atezolizumab plus bevacizumab is the fi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23f5ffb39c1f44fbca77060f06044a90
https://pubmed.ncbi.nlm.nih.gov/36107543
https://pubmed.ncbi.nlm.nih.gov/36107543
Publikováno v:
Oncotarget
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c1240e43216df44cb8bd321d84c38d3
https://doi.org/10.18632/oncotarget.27971
https://doi.org/10.18632/oncotarget.27971
Autor:
Hiroshi Kawakami, Yoshinori Ozono, Koji Nakashima, Koji Yamamto, Hiroyuki Tanaka, Hiroshi Hatada, Souichiro Ogawa, Hotaka Tamura, Keisuke Uchida, Naoki Yoshida, Naomi Uchiyama
Publikováno v:
Internal medicine (Tokyo, Japan). 61(10)
Panitumumab, a fully human anti-epidermal growth factor receptor (EGFR) monoclonal antibody, has been shown to be useful in treating either advanced or recurrent KRAS/NRAS/BRAF wild-type colorectal cancer. We herein report the case of a 60-year-old m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::41ad44786db0d0fa326c590eb77af56a
https://pubmed.ncbi.nlm.nih.gov/34744108
https://pubmed.ncbi.nlm.nih.gov/34744108
Autor:
Kenichi Nakamura, Kazunori Kusumoto, Hisayoshi Iwakiri, Satoru Hasuike, Mai Tsuchimochi, Fumiyo Toyoshima, Kotaro Shide, Yuuka Takaishi, Ayako Kamiunten, Takuro Kameda, Kazuya Shimoda, Tadashi Miike, Yoshinori Ozono, Kenji Nagata, Akira Sawaguchi
Publikováno v:
Hepatobiliary & Pancreatic Diseases International. 18:348-353
Background Monocyte-derived fibrocytes play an important role in the progression of fibrosis in the skin, lungs, heart and kidney. However, the contribution of fibrocytes to liver fibrosis is unclear. The aim of this study was to investigate whether
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35f40ea325945fe43e42a1dfb5224361
https://doi.org/10.1016/j.hbpd.2019.02.002
https://doi.org/10.1016/j.hbpd.2019.02.002
Autor:
Mai Tsuchimochi, Kenichi Nakamura, Kazunori Kusumoto, Toshihiro Mukuda, Kazuya Shimoda, Yunosuke Matsuura, Toshimasa Ochiai, Kazuo Kuroki, Kenji Nagata, Yoshinori Ozono, Hisayoshi Iwakiri, Satoru Hasuike
Publikováno v:
Anticancer research. 41(8)
Background/aim Direct-acting antiviral (DAA) therapies for patients with hepatitis C virus (HCV) infection deliver higher cure rates and lower frequencies of adverse events than existing therapies, though DAA treatment costs $45,000-64,000 in Japan.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e14d5ceb297452daba803d2e792be79
https://pubmed.ncbi.nlm.nih.gov/34281883
https://pubmed.ncbi.nlm.nih.gov/34281883
Autor:
Yoko Kubuki, Tomonori Hidaka, Takako Yokomizo-Nakano, Takuro Kameda, Yoshinori Ozono, Masaya Ono, Goro Sashida, Yuki Tahira, Sho Kubota, Ayako Kamiunten, Hisayoshi Iwakiri, Satoru Hasuike, Masaaki Sekine, Kazuya Shimoda, Kotaro Shide, Kenichi Nakamura, Kenji Nagata, Kazuhiko Ikeda, Keiichi Akizuki
Publikováno v:
Blood.
Mutations in JAK2, myeloproliferative leukemia virus (MPL), or calreticulin (CALR) occur in hematopoietic stem cells (HSCs) and are detected in more than 80% of patients with myeloproliferative neoplasms (MPNs). They are thought to play a driver role
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b9cbcda7f1a299acbf70d79581066bb
https://doi.org/10.1182/blood.2019003358
https://doi.org/10.1182/blood.2019003358
Autor:
Yoshinori Ozono, Kazuya Shimoda, Mitsue Sueta, Akira Sawaguchi, Kenichi Nakamura, Shojiro Yamamoto, Kenji Nagata, Yoko Kubuki, Ayako Kamiunten, Keiichi Akizuki, Hisayoshi Iwakiri, Tomonori Hidaka, Satoru Hasuike, Takuro Kameda, Yuki Tahira, Masaaki Sekine, Kotaro Shide
Publikováno v:
Leukemia
Primary myelofibrosis (PMF) is a myeloproliferative neoplasm (MPN) characterized by clonal myeloproliferation, progressive bone marrow (BM) fibrosis, splenomegaly, and anemia. BM fibrosis was previously thought to be a reactive phenomenon induced by
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::227b9309a2badabe1b58acded03e7378
https://pubmed.ncbi.nlm.nih.gov/32472085
https://pubmed.ncbi.nlm.nih.gov/32472085